Alvotech (ALVO)

• Market cap: $2.43B
• 1 day: -1.77%
• 5 days: -3.23%
• 1 month: -13.44%
• 3 months: -13.54%
• 6 months: -31.31%
• Year to date: -40.81%
• 1 year: -29.63%
• 5 years: -30.38%
• 10 years: -30.38%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.

Employees: 1,032

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

33% more funds holding in top 10

Funds holding in top 10: 3 [Q1] → 4 (+1) [Q2]

4% more funds holding

Funds holding: 50 [Q1] → 52 (+2) [Q2]

0.19% more ownership

Funds ownership: 5.52% [Q1] → 5.71% (+0.19%) [Q2]

2% less capital invested

Capital invested by funds: $159M [Q1] → $156M (-$3.23M) [Q2]

11% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 19

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $14
• Avg. target: $14
• High target: $14

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

UBS

$14

Buy Maintained

18 Jul 2025